Better Implements Poison Pill Amidst Garg's Control Fight

Online mortgage lender Better implemented a shareholder rights plan, widely referred to as a poison pill, on June 10, 2024, in response to increasing ownership by its co-founder and CEO, Vishal Garg. This strategic move is designed to prevent any single entity from acquiring a controlling stake in the company without board approval. The poison pill is set to remain in effect until June 10, 2027, and will be triggered if any individual or group accumulates 15% or more of Better's outstanding common stock or voting power. Upon triggering, the plan would allow existing shareholders, excluding the triggering party, to purchase additional shares at a discounted price, thereby diluting the ownership percentage of the party that exceeded the 15% threshold. This action signals a significant internal conflict at the company, as Garg has been steadily increasing his stake and influence. The move by the board aims to protect the interests of all shareholders and maintain the company's strategic direction, even if it means diluting the stake of its own CEO. Better, founded in 2014, has aimed to disrupt the traditional mortgage industry through technology, offering a streamlined online process for home buying and refinancing. The company has faced scrutiny and challenges in recent years, including layoffs and leadership changes, as it navigated a shifting economic landscape and sought profitability. Vishal Garg, who co-founded Better, has been a central figure in its development and has recently been reasserting his control. The adoption of the poison pill is a defensive tactic commonly employed by companies facing hostile takeover attempts or significant shifts in shareholder control. It effectively makes it more expensive and difficult for an individual to gain a majority or controlling interest. The board's decision to activate this measure suggests a deep division or disagreement regarding the future leadership and control of Better. The company's filings indicate that Garg's ownership has been approaching or exceeding the 15% threshold, prompting the board's action. This development underscores the ongoing power struggle within the company and its potential implications for Better's future operations, strategy, and governance. The effectiveness of the poison pill will depend on the specific terms of the plan and the subsequent actions of both Garg and the board. It is a significant escalation in the internal governance dispute, aiming to create a more balanced power dynamic and prevent a unilateral takeover. The company has not provided further details on the specific number of shares Garg currently holds or the exact percentage that triggered the board's concern, but the implementation of the poison pill itself is a clear indicator of the escalating situation. The plan's duration, set to expire in 2027, suggests a long-term strategy to stabilize control and governance during a period of internal contention.